檢索結果 - Nikolas Plevris
- Showing 1 - 10 results of 10
-
1
-
2
-
3
-
4
Multiple infliximab biosimilar switches appear to be safe and effective in a real‐world inflammatory bowel disease cohort 由 Beatriz Gros, Nikolas Plevris, Nathan Constantine‐Cooke, Mathew Lyons, Claire O'Hare, Colin Noble, Ian Arnott, Gareth‐Rhys Jones, Charlie W. Lees, L Derikx
出版 2023Artigo -
5
-
6
The ACE (Albumin, CRP and Endoscopy) Index in Acute Colitis: A Simple Clinical Index on Admission that Predicts Outcome in Patients With Acute Ulcerative Colitis 由 Rebecca K Grant, Gareth‐Rhys Jones, Nikolas Plevris, Ruairi Lynch, Philip Jenkinson, Charlie W. Lees, Thomas Manship, Fiona Jagger, William M Brindle, M Shivakumar, Jack Satsangi, Ian Arnott
出版 2020Artigo -
7
IBD prevalence in Lothian, Scotland, derived by capture–recapture methodology 由 Gareth‐Rhys Jones, Mathew Lyons, Nikolas Plevris, Philip Jenkinson, Cathy Bisset, Christopher Burgess, Shahida Din, James Fulforth, Paul Henderson, Gwo–Tzer Ho, Kathryn Kirkwood, Colin Noble, Alan G. Shand, David C. Wilson, Ian Arnott, Charlie W. Lees
出版 2019Artigo -
8
Vedolizumab is effective and safe in elderly inflammatory bowel disease patients: a binational, multicenter, retrospective cohort study 由 Nathaniel A. Cohen, Nikolas Plevris, Uri Kopylov, A Grinman, Bella Ungar, Henit Yanai, Haim Leibovitzh, Naomi Fliss‐Isakov, Ayal Hirsch, Einat Ritter, Yulia Ron, Ariella Bar‐Gil Shitrit, Eran Goldin, Iris Dotan, Shomron Ben–Horin, Charlie W. Lees, Nitsan Maharshak
出版 2020Artigo -
9
Real-world Effectiveness and Safety of Vedolizumab for the Treatment of Inflammatory Bowel Disease: The Scottish Vedolizumab Cohort 由 Nikolas Plevris, Cher Shiong Chuah, Rhiannon Allen, Ian Arnott, Paul Brennan, Sardar Chaudhary, A. M. D. Churchhouse, Shahida Din, Emma Donoghue, Daniel R. Gaya, M Groome, Hasnain Jafferbhoy, Philip Jenkinson, Wai Liam Lam, Mathew Lyons, Jonathan Macdonald, M MacMaster, Craig Mowat, Graham Naismith, Lindsay Potts, Eliana Saffouri, John Paul Seenan, Arjun Sengupta, P Shasi, Diarmid Sutherland, John A. Todd, Jennifer Veryan, Angus Watson, David Watts, Gareth‐Rhys Jones, Charlie W. Lees
出版 2019Artigo -
10
Effectiveness of ustekinumab dose escalation in Crohn’s disease patients with insufficient response to standard‐dose subcutaneous maintenance therapy 由 Uri Kopylov, Jurij Hanžel, Claire Liefferinckx, Davide De Marco, Nicola Imperatore, Nikolas Plevris, Iria Bastón‐Rey, Richard Harris, Marie Truyens, Viktor Domislović, Stephan R. Vavricka, Vince Biemans, Sally Myers, Shaji Sebastian, Shomron Ben–Horin, Yago González Lama, Cyrielle Gilletta, Bar‐Gil Shitrit Ariella, Zuzana Zelinková, Roni Weisshof, Darragh Storan, Eran Zittan, Klaudia Farkas, Tamás Molnár, Denis Franchimont, Anneline Cremer, Waqqas Afif, Fabiana Castiglione, Charlie W. Lees, Manuel Barreiro‐de Acosta, Triana Lobatón, Glen Doherty, Željko Krznarić, Marieke Pierik, Frank Hoentjen, David Drobne
出版 2020Artigo
相關主題
Internal medicine
Medicine
Disease
Inflammatory bowel disease
Gastroenterology
Calprotectin
Crohn's disease
Retrospective cohort study
Ulcerative colitis
Cohort
Faecal calprotectin
Adverse effect
Surgery
Cohort study
Colitis
Infliximab
Odds ratio
Vedolizumab
Adalimumab
Autoregressive integrated moving average
Biology
Biosimilar
C-reactive protein
Chemotherapy
Clinical endpoint
Clinical trial
Confidence interval
Demography
Discontinuation
Epidemiology